Search Results for 'hiv dtg'
hiv dtg published presentations and documents on DocSlides.
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
by jacey
1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Basic HIV Course for Health Professionals
by megan
Session 12: Contraceptives and HIV. Learning Objec...
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
10 th International Pediatric HIV Workshop
by faustina-dinatale
and 22. nd. International AIDS Conference . Sele...
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
10 th International Pediatric HIV Workshop
by luanne-stotts
and 22. nd. International AIDS Conference . Sele...
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
by liane-varnes
July 24 2018 . Overview on Safety of HIV Treatmen...
Antiretrovirals for prevention in women of childbearing age:
by tremblay
issues to consider. Landon Myer. We all have “is...
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
HIV History successes and lessons learned
by linda
PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...
The SA National PMTCT Guidelines (2019)
by cleminal
Outline. The ideal PMTCT pathway . Detail of new i...
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
by liane-varnes
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
by ethlyn
Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...
1 Queen Mary University, London, United Kingdom;
by trish-goza
1 Queen Mary University, London, United Kingdom; ...
1 Fundación Huésped, Buenos Aires, Argentina;
by aaron
2. Instituto Nacional de Ciencias Médicas y Nutr...
What’s New in WHO Treatment Guidelines
by aaron
July 23 2018 . What We Know About Safety Signals ...
HIV and Pregnancy: Current Consensus and Controversies
by elena
Jean Anderson, MD. Professor, Director of Division...
Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)
by alida-meadow
Treating and Preventing HIV in 2019: Interactive ...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
